2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
3
Thoracic
2
Gastrointestinal
2
Dermatologic
2
Other solid neoplasm
1
Other
1
Head & Neck
1
Genitourinary
1
Conditions
Prostatic Neoplasms
6268
Carcinoma, Renal Cell
1913
Urinary Bladder Neoplasms
1670
Kidney Neoplasms
930
Breast Neoplasms
793
Neoplasms
788
Carcinoma, Transitional Cell
592
Carcinoma, Non-Small-Cell Lung
524
Neoplasm Metastasis
510
Melanoma
484
Ovarian Neoplasms
468
Colorectal Neoplasms
454
Lung Neoplasms
435
Pancreatic Neoplasms
325
Testicular Neoplasms
290
Stomach Neoplasms
274
Sarcoma
266
Uterine Cervical Neoplasms
264
Non-Muscle Invasive Bladder Neoplasms
263
Head and Neck Neoplasms
241
Colonic Neoplasms
217
Esophageal Neoplasms
203
Squamous Cell Carcinoma of Head and Neck
202
Carcinoma, Hepatocellular
197
Wilms Tumor
196
Endometrial Neoplasms
189
Recurrence
162
Neuroblastoma
148
Urologic Neoplasms
147
Small Cell Lung Carcinoma
146
Interventions
Cyproterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Acne Vulgaris
×
Genitourinary
×
Clear all
NCT04925180
2022-01-12
Safe-CAM
Bayer
Completed
600 enrolled